Biostar Pharmaceuticals, Inc.

BSPM · OTC
Analyze with AI
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Assets
Cash & Equivalents$173$39$1,685$80
Short-Term Investments$0$0$0$0
Receivables$6,854$15,891$36,802$31,639
Inventory$167$235$674$830
Other Curr. Assets$171$0$4,472$3,436
Total Curr. Assets$7,365$16,167$43,633$35,986
Property Plant & Equip (Net)$5,867$6,811$8,483$7,729
Goodwill$0$0$0$0
Intangibles$5,607$6,879$13,270$17,134
Long-Term Investments$0$0$0$0
Tax Assets$2,515$5,407$7,066$2,789
Other NC Assets$21,148$16,100$8,795$3,927
Total NC Assets$35,137$35,196$37,614$31,579
Other Assets$0$0$0$0
Total Assets$42,502$51,364$81,247$67,564
Liabilities
Payables$2,842$4,153$5,001$4,447
Short-Term Debt$2,326$2,773$3,095$0
Tax Payable$0$113$433$344
Deferred Revenue$0$113$433$0
Other Curr. Liab.$455-$53-$50$0
Total Curr. Liab.$5,623$7,098$8,912$4,792
LT Debt$0$0$0$0
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$0$0$0$0
Total NC Liab.$0$0$0$0
Other Liabilities$0$0$0$0
Cap. Leases$0$0$0$0
Total Liabilities$5,623$7,098$8,912$4,792
Equity
Pref Stock$0$0$0$0
Common Stock$3$2$15$13
Retained Earnings-$2,541$3,157$28,270$23,650
AOCI$8,035$10,789$13,746$13,727
Other Equity$31,382$30,317$30,317$25,749
Total Equity$36,879$44,265$72,335$62,773
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$42,502$51,364$81,247$67,564
Net Debt$2,152$2,734$1,409-$80